PLAU, plasminogen activator, urokinase, 5328

N. diseases: 439; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.060 Biomarker disease BEFREE The role of SPINK13 in cellular proliferation, apoptosis and migration is uPA dependent, and SPINK13 may be used as a potential biomarker for diagnosis and targeted therapy in OC. 29439245 2018
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.060 Biomarker disease LHGDN Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway. 17611702 2007
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.060 Biomarker disease LHGDN Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system. 17187779 2007
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.060 GeneticVariation disease BEFREE The above findings suggest the applicability of therapeutic strategies targeting the inhibition of peritoneal invasion and dissemination of ovarian cancer by the use of the chimeric gene ATF-HI8. 15386422 2005
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.060 AlteredExpression disease LHGDN Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. 15653692 2005
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.060 GeneticVariation disease BEFREE In order to elucidate the possible role of the Pro121Leu exchange in uPA and the Ala/Thr variants in the signal sequence of PAI-1 in the development and/or progression of human ovarian cancer, we studied the presence of these mutants or variants in a series of 22 ovarian cancer tissues. 9194591 1997